⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20122518 | 0.97 | — | — | |
| SCHEMBL20122399 | 0.94 | — | — | |
| SCHEMBL20122464 | 0.92 | — | — | |
| SCHEMBL20122427 | 0.90 | CYP1A2 (0.33) | — | |
| SCHEMBL20122437 | 0.90 | — | — | |
| SCHEMBL20122453 | 0.90 | — | — | |
| SCHEMBL20122542 | 0.89 | — | — | |
| SCHEMBL20122426 | 0.89 | — | — | |
| SCHEMBL20122554 | 0.88 | — | — | |
| SCHEMBL20122593 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9963428-B1 | Bucillamine prodrugs, pharmaceutical compositions thereof, and methods of use | Nguyen, Mark Quang (US) | 2018-05-08 | — | — | US | disclosed |